Identifying patients with Crohn's disease at high risk of primary nonresponse to infliximab using a radiomic-clinical model.
Xuehua LiYingkui ZhongChenglang YuanJinjiang LinXiaodi ShenMinyi GuoBaolan LuJixin MengYangdi WangNaiwen ZhangZixin LuoGuimeng HuRen MaoMinhu ChenCanhui SunZiping LiQing-hua CaoBaili ChenZhihui ChenBingsheng HuangShi-Ting FengPublished in: Int. J. Intell. Syst. (2022)